http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104288168-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104288168-B |
| titleOfInvention | Purposes of the cryptogenin in the medicine for preparing the disease for being used for treating and/or prevent microglia to mediate |
| abstract | It is used for the new application of the relevant disease such as disease such as cerebral apoplexy, Alzheimer disease, Parkinson's, brain trauma, multiple sclerosis, amyotrophic lateral sclerosis, aids related dementia, rabid ox disease for preventing and/or treating microglia mediation the present invention relates to cryptogenin.The traditional Chinese medicine monomer cryptogenin that the present invention is provided has following New function：The inflammatory mediator NO of activated microglia generation can substantially be suppressed, suppress microglial activation inducing cell death.Therefore, cryptogenin can apply to the preventing and treating of the brain immunoinflammatory relevant disease such as cerebral apoplexy, Alzheimer disease, Parkinson's, brain trauma, encephalitis, multiple sclerosis. |
| priorityDate | 2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 372.